Openbookopenbook
Equity
IDEXX Laboratories Inc(IDXX)
USD --+0.00%
Reward61Moderate
Risk30Moderate
📊75%Data
Strong 25% profit margin · Revenue growing 14% YoY
IDXX
+0.0 · +0.00%
USD · NASDAQ
IDEXX Laboratories Inc | Healthcare
Quality Compounder
Market Cap:52.59Bn
ℹ️
Reward Rating
61
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
30
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on IDXX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $750.23.

What is IDEXX Laboratories Inc?

develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.

IDXX · Verdict

Solid reward · low risk

IDXX stands out on cash flow and profitability, but watch the valuation signal.

Based on 88% data coverage

IDXX · Verdict

What’s working & what to watch

Strengths 4

  • Cash flow95/100

    24% free-cash-flow margin

  • Profitability93/100

    25% net margin · 66% ROE

  • Balance sheet82/100

    Interest covered 35.6×

  • Growth69/100

    Rev +8.5% CAGR · earnings +16.0%

Watchouts 2

  • Valuation15/100

    P/E 44.6× · PEG 4.22

  • Volatility20/100

    Weak vs peers

Model-based scoring. For information only — not financial advice.

What is IDEXX Laboratories Inc?

develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 52.59B, and a P/E ratio of 50.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (61)

The scoring profile indicates moderate reward potential, with profitability and growth as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap52.59B
P/E Ratio50.2584
Dividend YieldN/A
52 Week High769.98
52 Week Low356.14
Last AnnualDecember
IPO Date6/21/1991
IncorporatedUSA
Shares Outstanding80M
No. of Employees11,000
IndustryDiagnostics & Research
ExchangeNASDAQ
Beta1.66
CurrencyUSD
Websitewww.idexx.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.